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Introduction
Sickle  cell  anemia  is  a  hereditary  disease  caused  by  the
presence  of  hemoglobin  S,  an  abnormal  type  of  hemoglobin.
Hemolytic  and  vaso-occlusive  crises  are  the  main  manifes-
tations  of  sickle  cell  anemia.1 Deoxygenation  of  hemoglobin
S  may  result  in  intracellular  hemoglobin  polymerization,
which  changes  the  cell  morphology  and  ﬂexibility.  The
loss  of  red  blood  cell  ﬂexibility  results  in  occlusion  of
the  capillaries  and  subsequent  vaso-occlusive  crises.  Vaso-
occlusive  crises  are  experienced  as  severe  pain  attacks.
Recurrent  vaso-occlusive  crises  may  result  in  stroke,  renal
dysfunction,  pulmonary  hypertension,  retinal  disease,  and
avascular  necrosis.1,2 Infection,  hypoxia,  dehydration,  acid-
osis,  overexercise,  psychological  stress,  trauma,  cocaine
use,  cold  exposure,  and  high  altitude  are  the  predisposing
factors  to  vaso-occlusive  crises.1 Most  of  these  factors
may  be  seen  during  general  anesthesia  and  may  be  con-
trolled  by  antibiotic  prophylaxis,  oxygenation,  hydration,
maintenance  of  body  temperature,  and  postoperative  pain
control.3--5 As  with  other  types  of  esthetic  surgery,  rhino-
plasty  is  an  elective  procedure  and  might  be  avoided  in
this  high-risk  patient  group.  This  probably  explains  why
 Please cite this article as: C¸ag˘ıcı CA, Asma S, S¸ener M.
Septorhinoplasty in sickle cell anemia: a case report. Braz J Otorhi-
nolaryngol. 2016. http://dx.doi.org/10.1016/j.bjorl.2016.08.001
∗ Corresponding author.
E-mail: ccagici@hotmail.com (C.A. C¸ag˘ıcı).
p
r
w
l
http://dx.doi.org/10.1016/j.bjorl.2016.08.001
1808-8694/© 2016 Associac¸a˜o Brasileira de Otorrinolaringologia e Cirurgia
access article under the CC BY license (http://creativecommons.org/lice  found  no  reports  on  this  topic  in  the  literature.  The
urrent  case  is  believed  to  be  the  ﬁrst  esthetic  opera-
ion  in  a  patient  with  sickle  cell  anemia,  which  makes
ny  surgical  procedure  requiring  anesthesia  a  high-risk
rocedure.
ase report
 29-year-old  woman  presented  with  nasal  obstruction.  The
eptum  was  deviated  to  the  left.  Her  internal  valve  was  nar-
ow  on  the  left  side.  She  desired  to  breathe  through  the
ose  easily  and  requested  correction  of  the  external  defor-
ity  (Figs.  1--3)  at  the  time  of  surgical  correction  of  the
eptum  deviation.  She  had  a history  of  septoplasty  and  was
eing  followed  by  the  hematology  department  because  of
ickle  cell  anemia.  The  patient  provided  written  permission
or  the  publication  of  her  photographs.
Laboratory  examination  revealed  a  serum  sodium
oncentration  of  138  mEq/L,  potassium  of  4.81  mEq/L,  cal-
ium  of  9.19  mg/dL,  phosphorus  of  3.63  mg/dL,  blood  urea
itrogen  of  10  mg/dL,  serum  creatinine  of  0.44  mg/dL,
nd  uric  acid  of  3.32  mg/dL.  The  red  cell  count  was
.87  ×  106 mm3, white  blood  cell  count  was  5960  mm3,
emoglobin  concentration  was  8.4  g/dL,  and  hematocrit  was
5.7%.  Her  activated  partial  thromboplastin  time  was  <26  s,
rothrombin  time  was  13.8  s,  and  international  normalized
atio  was  1:1.  Her  aspartate  aminotransferase  concentration
as  35  IU/L,  alanine  aminotransferase  was  20  IU/L,  alka-
ine  phosphatase  was  55  IU/L,  and  -glutamyltransferase
 Ce´rvico-Facial. Published by Elsevier Editora Ltda. This is an open
enses/by/4.0/).
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aFigure  1  Frontal  view  of  the  patient,  preope
as  25  IU/L.  Her  serum  lactic  dehydrogenase  concentration
as  high  at  346  IU/L  (normal  range,  90--240).  Her  C-reactive
rotein  concentration  was  <3  mg/L,  and  her  erythrocyte  sed-
mentation  rate  was  high  at  61  mm/h.
The  hematology  department  evaluated  the  patient  pre-
peratively.  We  administered  two  bags  of  erythrocyte
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Figure  2  Lateral  view  of  the  patient,  preoperatively  (left)  and  1  month  postoperatively  (right).
uspension  3  days  before  surgery,  and  her  hematocrit
nd  hemoglobin  concentrations  increased  from  25.7%  and
.4  g/dL  to  32.0%  and  11.0  g/dL,  respectively.  She  was  eval-
ated  by  the  anesthesiology  department  and  determined
o  have  an  American  Society  of  Anesthesiologists  physical
tatus  of  II.
ely  (left)  and  1  month  postoperatively  (right).
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aFigure  3  Basal  view  of  the  patient,  preoper
We  entered  the  septum  through  a  transﬁxion  incision.  The
septum  was  deviated  to  the  left.  We  observed  a  wide  L  strut
that  had  been  left  in  place  during  the  previous  septoplasty.
Although  it  was  sufﬁcient  in  width,  the  L  strut  was  not  strong
enough  to  support  the  dorsum  and  had  to  be  enhanced.  We
took  cartilage  grafts  from  the  septum  by  lifting  the  intact
L  strut,  which  was  1  cm  wide.  We  enhanced  the  septum  by
suturing  the  cartilage  grafts  to  the  L  strut  from  the  right
side.
The  lower  lateral  cartilages  were  delivered  from  the
infracartilaginous  and  intercartilaginous  incisions.  We  per-
formed  minimal  cephalic  resection  on  both  sides.  We  sutured
the  domes  from  the  cephalic  sides.  The  domes  were  approx-
imated  by  interdomal  sutures.  We  required  a  cap  and  lateral
crural  strut  grafts  and  decided  to  take  the  grafts  from  the
auricular  cartilage.  We  took  a  conchal  cartilage  graft  from
the  right  side.  The  donor  side  was  closed  primarily.  The
cap  graft  was  sutured  to  the  tip  using  5/0  polyglycolic  acid
suture.  A  lateral  crural  strut  graft  was  placed  under  the  left
lower  lateral  cartilage.
We  rasped  the  hump  and  the  convexity  on  the  right  nasal
bone.  The  cartilage  framework  was  closed  using  5--0  poly-
dioxanone  sutures.  Two  layers  of  crushed  cartilage  were
placed  on  the  supra-tip  area.  Alar  base  resection  was  per-
formed  on  the  left  side.  Doyle  splints  were  introduced  in  the
nasal  passages.  An  external  thermal  nasal  splint  was  applied.
The  operation  was  terminated  without  complication.
The  septorhinoplasty  procedure  was  performed  under
general  anesthesia.  We  closely  followed  the  patient’s  oxy-
gen  saturation,  a  decrease  in  which  may  trigger  a  sickle  cell
crisis.  The  minimum  oxygen  saturation  was  99%.  The  patient
was  heated  perioperatively  with  a  patient-warming  system.
We  did  not  use  epinephrine  to  avoid  a  possible  vaso-occlusive
c
w
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lly  (left)  and  1  month  postoperatively  (right).
risis,  and  we  used  only  2%  lidocaine  hydrochloride  as  the
ocal  anesthetic.  Additionally,  we  did  not  place  an  ice  bag
n  the  face,  which  we  routinely  use  in  patients  undergoing
hinoplasty.
The  postoperative  period  was  uneventful  without  any
ajor  hemorrhage.  We  did  not  administer  additional  eryth-
ocyte  suspension.  On  postoperative  day  1,  the  hematocrit
nd  hemoglobin  concentration  were  25.2%  and  8.9  g/dL,
espectively.  There  were  no  circulation  problems  in  the  nasal
kin  in  either  the  early  or  late  postoperative  period.  At
he  time  of  this  writing,  the  patient  was  breathing  easily
hrough  her  nose  and  was  happy  with  her  external  appear-
nce  (Figs.  1--3).
iscussion
eptorhinoplasty  is  the  most  frequently  performed  esthetic
peration.  However,  there  are  no  data  in  the  literature
bout  esthetic  surgery  in  patients  with  sickle  cell  anemia.
e  performed  septorhinoplasty  by  a closed  approach  in  a
atient  with  sickle  cell  anemia,  and  this  case  is  believed
o  be  the  ﬁrst  esthetic  operation  in  this  patient  group.  The
losed  approach  is  our  preference  for  this  procedure.
Hemoglobin  S,  which  is  less  ﬂexible  than  normal
emoglobin,  causes  occlusion  of  the  capillaries  and  sub-
equent  vaso-occlusive  crises.  A  decreased  hemoglobin  S
oncentration  and  improvement  of  anemia  by  preoper-
tive  blood  transfusion  lowers  the  risk  of  postoperative
omplications  in  patients  with  sickle  cell  disease.6 Patients
ith  sickle  cell  anemia  may  undergo  either  simple  or
xchange  transfusion.  In  simple  transfusion,  the  hemoglobin
evel  increases  secondary  to  the  blood  transfusion.  In
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xchange  transfusion,  the  hemoglobin  S  is  removed  from
he  patient’s  blood  and  replaced  by  a  blood  transfusion
rom  a  healthy  individual.  The  goal  of  the  exchange  transfu-
ion  is  to  decrease  the  hemoglobin  S  concentration  to  <30%.
he  exchange  transfusion  has  the  advantages  of  decreasing
he  hemoglobin  S  level  without  increasing  the  hematocrit
nd  viscosity  of  blood.3 On  the  one  hand,  a  Cochrane
eview  reported  no  difference  between  simple  and  exchange
ransfusion  in  terms  of  preventing  complications  of  surgery
r  sickle  cell  anemia;  however,  the  review’s  evidence  for
his  lack  of  difference  was  insufﬁcient.7 On  the  other
and,  blood  transfusion  is  associated  with  serious  potential
omplications  such  as  transmission  of  infection,  iron  over-
oad,  and  transfusion  reactions.7 Although  the  transfusion
ay  be  performed  within  2  weeks  before  surgery,  it  should
e  performed  24  h  before  surgery  to  maintain  a  high  oxygen
ransport  capacity.7
The  sickling  of  erythrocytes  in  sickle  cell  anemia  results
n  vaso-occlusive  crises,  which  may  cause  organ  damage  and
ain.  These  crises  may  be  triggered  by  infection,  acidosis,
rauma,  cocaine  use,  exposure  to  cold,  stress,  dehydra-
ion,  and  hypoxia.1 Most  of  these  predisposing  factors  for
aso-occlusive  crises  may  be  seen  during  general  anesthe-
ia  and  must  be  avoided.  Hypothermia,  which  may  result  in
ickling  of  erythrocytes,  should  be  avoided.  This  may  be  eas-
ly  achieved  by  heating  of  the  operation  room  or  patient.3
pplication  of  a  cold  pack  to  the  face,  which  is  routinely
pplied  postoperatively  in  rhinoplasty,  must  also  be  avoided.
erioperative  hydration  of  the  patient  is  important,  as  is
eeping  the  patient  warm.  Hypoxia  may  also  trigger  sickling.
eneral  anesthesia  temporarily  lowers  the  oxygen  level  in
he  blood,  which  could  be  dangerous  for  patients  with  sickle
ell  anemia.  Therefore,  the  oxygen  saturation  must  also  be
losely  monitored.  Furthermore,  some  medications  (e.g.,
econgestants  such  as  pseudoephedrine  or  epinephrine)  can
ause  vasoconstriction  and  make  it  more  difﬁcult  for  the
ickle  cells  to  move  freely  through  the  blood  vessels.  A  local
nesthetic  solution  that  does  not  contain  epinephrine  should
e  used  in  patients  with  sickle  cell  anemia.  With  proper
are,  operations  under  general  anesthesia  may  be  safe  in
atients  with  sickle  cell  anemia.  Avoidance  of  dehydration,
 low  body  temperature,  and  oxygen  desaturation  as  well  as
he  use  of  a  local  anesthetic  solution  without  epinephrine
hould  be  ensured.3 All  of  these  precautions  are  also  valid
or  esthetic  surgery.
Physiologically,  it  is  important  to  breathe  through  the
ose.  Nasal  obstruction  and  breathing  through  the  mouth
s  not  healthy,  disturbs  the  quality  of  the  life,  and  has  to
e  corrected.  Septal  deviation  is  the  most  frequently  seen
tiological  factor  of  nasal  obstruction,  which  is  corrected
y  septoplasty.  In  the  present  case,  the  patient  had  weak
eptal  cartilage  that  deviated  caudally.  We  corrected  the
eviation  and  enhanced  the  septum  using  cartilage  grafts.
he  patient  also  had  internal  nasal  valve  collapse,  which
erved  as  another  cause  of  nasal  obstruction.  Her  left  lower
artilage  was  hypoplastic  and  corrected  with  a  lateral  cru-
al  strut  graft.8 We  placed  this  graft  in  the  submucosal
ocket  under  the  lateral  crus  to  support  the  side  wall.  Vis-
bility  of  the  cephalic  edge  of  the  cartilage  graft  might  be
 potential  drawback  of  this  technique;  however,  it  was  not
ncountered  in  the  present  case,  and  nasal  breathing  was
uccessfully  achieved.
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What  is  the  importance  of  esthetic  surgery  in  patients
ith  a  chronic  disease  such  as  sickle  cell  anemia?  Living
ith  a  chronic  disease  can  cause  anxiety  and  stress,  which
ften  leads  to  depression.  As  with  cosmetics,  feeling  more
ttractive  improves  the  patient’s  mood,  and  feeling  bet-
er  helps  the  patient  to  live  with  the  chronic  disease  and
ncreases  their  quality  of  life.  This  is  especially  important
or  patients  with  a  chronic  disease.  Our  patient  did  not
eek  pure  esthetic  rhinoplasty.  We  added  esthetic  rhino-
lasty  to  the  septoplasty  operation.  Before  the  present
ase,  we  would  not  normally  have  accepted  a  request  for
ure  rhinoplasty  from  a  patient  with  sickle  cell  anemia.
ur  perspective  changed  after  seeing  that  rhinoplasty  was
ossible  in  a  patient  with  sickle  cell  anemia  with  proper
erioperative  care,  but  we  are  still  undecided.  On  one
and,  esthetic  surgery  is  elective  and  should  be  avoided
n  high-risk  patient  groups.  On  the  other  hand,  we  believe
hat  improving  the  outlook  of  patients  during  manage-
ent  of  chronic  diseases  is  as  important  as  treating  the
isease.
onclusion
ith  proper  perioperative  care,  septorhinoplasty  may  be
erformed  in  patients  with  sickle  cell  anemia.
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